C1 inhibitor (human)
Ended Awarded Last action
- Contract number
- 36C24826F0091
- Awardee
-
CSL Behring L.L.C. UEI H3WKVE9VBLY3
- Awarding agency
-
Veterans Integrated Service Network 8
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $147,122
Award facts
- Contract value 100% obligated
- $147,122.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- King of Prussia, PA 19406, USA
Award details come from SAM.gov/FPDS.
About this award
CSL Behring LLC has been awarded a delivery order by Veterans Integrated Service Network 8 for C1 Inhibitor (Human) pharmaceutical products, effective February 27, 2026, with a firm fixed price ceiling value of $147,122.08 and an ultimate completion date of March 27, 2026. The award carries no set-aside designation and is performed at CSL Behring's facility in King of Prussia, Pennsylvania. This delivery order is issued under the company's parent Federal Supply Schedule contract (FSS-61-IB) for Pharmaceuticals and Drugs, a $201.48 million multiple-award vehicle awarded by VISN 12 on September 30, 2021, and valid through September 29, 2026.
CSL Behring, a global biotherapeutics company specializing in plasma-derived and recombinant therapies, serves as the prime contractor with no identified subcontractors on this award. The company has established itself as a critical supplier to the Veterans Health Administration through multiple delivery orders and blanket purchase agreements across numerous VISNs since 2021. The C1 inhibitor products provided under this and related contracts support the treatment of hereditary angioedema and other hematological conditions for veterans nationwide, complementing CSL Behring's portfolio of specialty pharmaceuticals including HAEGARDA, Privigen, Hizentra, and Kcentra supplied to VA medical facilities.
Quick answers
Who was awarded contract 36C24826F0091?
36C24826F0091 was awarded to CSL Behring L.L.C. by Veterans Integrated Service Network 8 (Veterans Health Administration) on February 27, 2026.
How much is contract 36C24826F0091 worth?
The government has obligated $147,122 on 36C24826F0091.
Is contract 36C24826F0091 an order under another contract?
Yes. 36C24826F0091 is a delivery order under 36F79721D0249, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24826F0091 competed?
The extent of competition for 36C24826F0091 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award